Literature DB >> 23147656

Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD.

Rafael Denadai, Fábio V Teixeira, Rogério Saad-Hossne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23147656     DOI： 10.1038/nrgastro.2012.125-c1

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

Review 2.  Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.

Authors:  G Cullen; D Kroshinsky; A S Cheifetz; J R Korzenik
Journal:  Aliment Pharmacol Ther       Date:  2011-09-29       Impact factor: 8.171

3.  Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy.

Authors:  Jean-François Rahier; Sébastien Buche; Laurent Peyrin-Biroulet; Yoram Bouhnik; Bernard Duclos; Edouard Louis; Pavol Papay; Matthieu Allez; Jacques Cosnes; Antoine Cortot; David Laharie; Jean-Marie Reimund; Marc Lémann; Emmanuel Delaporte; Jean-Frédéric Colombel
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-20       Impact factor: 11.382

4.  Infliximab-induced psoriasis during therapy for Crohn's disease.

Authors:  Flavio Steinwurz; Rafael Denadai; Rogério Saad-Hossne; Maria Luiza Queiroz; Fábio Vieira Teixeira; Ricardo Romiti
Journal:  J Crohns Colitis       Date:  2012-01-26       Impact factor: 9.071

5.  Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.

Authors:  Daniel C Baumgart; Ulrike Grittner; Andrea Steingräber; Marina Azzaro; Sandra Philipp
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

Review 6.  Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.

Authors:  Angelique N Collamer; Daniel F Battafarano
Journal:  Semin Arthritis Rheum       Date:  2010-06-26       Impact factor: 5.532

7.  Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.

Authors:  H-H Lee; I-H Song; M Friedrich; A Gauliard; J Detert; J Röwert; H Audring; S Kary; G-R Burmester; W Sterry; M Worm
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

Review 8.  The onset of psoriasis during the treatment of inflammatory bowel diseases with infliximab: should biological therapy be suspended?

Authors:  Rafael Denadai; Fábio Vieira Teixeira; Rogério Saad-Hossne
Journal:  Arq Gastroenterol       Date:  2012 Apr-Jun

Review 9.  Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases.

Authors:  Rafael Denadai; Fábio Vieira Teixeira; Flavio Steinwurz; Ricardo Romiti; Rogério Saad-Hossne
Journal:  J Crohns Colitis       Date:  2012-09-07       Impact factor: 9.071

10.  Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

Authors:  M J Harrison; W G Dixon; K D Watson; Y King; R Groves; K L Hyrich; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2008-04-02       Impact factor: 19.103
  10 in total
  2 in total

Review 1.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 2.  Psoriasis and inflammatory bowel disease: links and risks.

Authors:  Christoforos Vlachos; Georgios Gaitanis; Konstantinos H Katsanos; Dimitrios K Christodoulou; Epameinondas Tsianos; Ioannis D Bassukas
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.